German Consensus Recommends Second-Generation Gene Silencers for Hereditary Transthyretin Polyneuropathy
German neurological and amyloidosis societies recommend second-generation gene silencers as first-line therapy for symptomatic hereditary transthyretin amyloidosis with polyneuropathy.


